Every open market buy and sale of Cartesian Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $206K bought and $259K sold.
Buying and selling by month
open market, last 12 monthsGet an alert when RNAC insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an RNAC officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every RNAC insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Blaine DavisCFO | Sale | 10,591 | $6.82 | $72K | 121,220 | Jan 8Form 4 |
| Jan 6, 2026 | Milos MiljkovicChief Medical Officer | Sale | 3,573 | $6.82 | $24K | 58,820 | Jan 8Form 4 |
| Jan 6, 2026 | Carsten BrunnPresident and CEO | Sale | 23,766 | $6.82 | $162K | 323,530 | Jan 8Form 4 |
| Dec 4, 2025 | Timothy C BarabeDirector | Buy | 30,000 | $6.86 | $206K | 54,366 | Dec 8Form 4 |
| Apr 11, 2025 | Timothy A SpringerDirector | Buy | 149,075 | $10.21 | $1.5M | 656,513 | Apr 11Form 4 |
| Mar 20, 2025 | Timothy A SpringerDirector | Buy | 89,863 | $15.26 | $1.4M | 8,621,325 | Mar 20Form 4 |
| Jan 14, 2025 | Timothy A SpringerDirector | Buy | 20,967 | $17.47 | $366K | 8,531,462 | Jan 15Form 4 |
| Jan 6, 2025 | Blaine DavisCFO | Sale | 7,989 | $16.78 | $134K | 94,811 | Jan 7Form 4 |
| Jan 6, 2025 | Carsten BrunnPresident and CEO | Sale | 17,271 | $16.78 | $290K | 204,096 | Jan 7Form 4 |
| Jan 6, 2025 | Emily EnglishChief Operations Officer | Sale | 1,797 | $16.78 | $30K | 40,226 | Jan 7Form 4 |
| Jan 6, 2025 | Christopher M JewellChief Scientific Officer | Sale | 2,550 | $16.78 | $43K | 53,490 | Jan 7Form 4 |
| Jan 6, 2025 | Milos MiljkovicChief Medical Officer | Sale | 1,880 | $16.78 | $32K | 35,393 | Jan 7Form 4 |
| Jan 6, 2025 | Metin KurtogluChief Technology Officer | Sale | 4,875 | $16.78 | $82K | 62,258 | Jan 7Form 4 |
| Dec 23, 2024 | Timothy A SpringerDirector | Buy | 52,189 | $18.49 | $965K | 8,507,895 | Dec 23Form 4 |
| Dec 10, 2024 | Metin KurtogluChief Technology Officer | Sale | 13,664 | $25.26 | $345K | 51,033 | Dec 11Form 4 |
RNAC insider trading FAQ
Are RNAC insiders buying or selling?
Insiders are net sellers over the last 12 months. 1 insiders bought $206K of RNAC on the open market in 1 trades, and 3 sold $259K in 3 trades.
When did an RNAC insider last buy shares?
Timothy C Barabe (Director) bought 30,000 shares for $206K on Dec 4, 2025, reported on Dec 8, 2025.
When did an RNAC insider last sell shares?
Blaine Davis (CFO) sold 10,591 shares for $72K on Jan 6, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
